Back to Search Start Over

[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.

Authors :
Hermans MP
Valensi P
Ahn SA
Rousseau MF
Source :
Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2018 Jan; Vol. 34 (1). Date of Electronic Publication: 2017 Oct 16.
Publication Year :
2018

Abstract

Aims: Although women have higher high-density lipoprotein cholesterol (HDL-C) than have men, their HDL particles are also prone to become small, dense, and dysfunctional in case of type 2 diabetes mellitus (T2DM). To assess the vascular risk related to HDLs of different sizes/densities without direct measurement, we adjusted HDL-C to its main apolipoprotein (apoA-I) as [HDL-C/apoA-I]. This ratio estimates HDL sizes and provides indices as to their number, cholesterol load, and density.<br />Methods: We stratified 280 Caucasian T2DM women according to [HDL-C/apoA-I] quartiles (Q) to determine how they are segregated according to cardiometabolic risk, β-cell function, glycaemic control, and vascular complications. Five parameters were derived from combined determination of HDL-C and apoA-I: HDL size, HDL number, cholesterol load per particle (pP), apoA-I pP, and HDL density.<br />Results: An adverse cardiometabolic profile characterized QI and QII patients whose HDLs were denser and depleted in apoA-I, whereas QIII patients had HDLs with characteristics closer to those of controls. QIV patients had HDLs of supernormal size/composition and a more favourable phenotype in terms of fat distribution; insulin sensitivity (64% vs 41%), metabolic syndrome, and β-cell function (32% vs 23%); exogenous insulin (44 vs 89 U·d <superscript>-1</superscript> ); and glycaemic control (glycated haemoglobin, 56 vs 61 mmol·mol <superscript>-1</superscript> ), associated with lower prevalence of microvascular/macrovascular complications: all-cause microangiopathy 47% vs 61%; retinopathy 22% vs 34%; all-cause macroangiopathy 19% vs 31%; and coronary artery disease 6% vs 24% (P < .05).<br />Conclusion: [HDL-C/apoA-I] can stratify T2DM women according to metabolic phenotype, macrovascular and coronary damage, β-cell function, microangiopathic risk, and retinopathy. This ratio is a versatile and readily available marker of cardiometabolic status and vascular complications in T2DM women.<br /> (Copyright © 2017 John Wiley & Sons, Ltd.)

Details

Language :
English
ISSN :
1520-7560
Volume :
34
Issue :
1
Database :
MEDLINE
Journal :
Diabetes/metabolism research and reviews
Publication Type :
Academic Journal
Accession number :
28921828
Full Text :
https://doi.org/10.1002/dmrr.2950